The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted
Adding preoperative chemoradiotherapy to perioperative chemotherapy failed to boost survival, versus perioperative chemotherapy alone, in resectable gastric and gastroesophageal junction (GEJ) adenocarcinoma, according to TOPGEAR
Trastuzumab deruxtecan (Enhertu, T-DXd) therapy produced “substantial and durable” overall and intracranial clinical activity in patients with HER2-positive advanced breast cancer, according to data from
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,
Lowe Taylor is a physiatrist. In 2018, I was a young medical resident working on a spinal cord injury unit at the Palo Alto Veterans